Product image of Mikanisal (Ketoconazole) supplied by GNH India

Mikanisal

Active Ingredient:
Ketoconazole
Origin:
EU

Mikanisal (Ketoconazole)

Ketoconazole, the active ingredient in Mikanisal, is an imidazole antifungal presented as a topical formulation for skin application. It treats superficial fungal infections such as athlete’s foot, ringworm and seborrheic dermatitis in adults and children.

GNH India supplies Mikanisal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality‑assured batches, regulatory compliance and reliable logistics for global healthcare providers.

Manufacturer / TM Owner

Grindeks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ketoconazole is applied topically to manage fungal skin conditions by inhibiting the growth of dermatophytes and yeasts.

  • Tinea corporis: reduces fungal proliferation and promotes clearance of ring‑shaped lesions.
  • Tinea cruris: alleviates itching and erythema in the groin area caused by fungal infection.
  • Tinea pedis: treats athlete’s foot, diminishing scaling and discomfort.
  • Seborrheic dermatitis: controls Malassezia‑related inflammation on scalp and face.
  • Other superficial fungal skin infections: effective against a range of dermatophyte and yeast infections on the skin.

How It Works

  • Ketoconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, a key step in ergosterol synthesis. By blocking ergosterol production, the drug disrupts the integrity of the fungal cell membrane, leading to increased permeability and ultimately cell death, thereby eliminating the infection at the site of application.

Side Effects

Topical ketoconazole may cause local and systemic reactions, most of which are mild.

Common Side Effects

  • Skin irritation: mild redness or itching at the application site.
  • Burning sensation: transient warmth or stinging after application.
  • Dryness: mild peeling or flaking of treated skin.
  • Pruritus: occasional itching unrelated to infection.

Serious or Rare Side Effects

  • Allergic contact dermatitis: widespread rash, swelling, or hives requiring medical attention.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis, extremely rare but serious.
  • Systemic absorption effects: hepatotoxicity or hormonal disturbances reported rarely with extensive use.

Precautions & Warnings

Before using Mikanisal, consider the following safety measures.

  • Pregnancy: consult a healthcare provider before use, as safety data are limited.
  • Breastfeeding: evaluate risk‑benefit, ketoconazole may be excreted in milk.
  • Extensive body surface area: limit application to avoid significant systemic absorption.
  • Concomitant liver disease: monitor liver function if large areas are treated.
  • Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Ketoconazole can interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid)

  • Systemic azoles (e.g., itraconazole, fluconazole): combined use may increase risk of hepatotoxicity.
  • Topical corticosteroids: may mask infection signs, reducing treatment effectiveness.
  • Warfarin: ketoconazole can potentiate anticoagulant effect if absorbed systemically.

Moderate Interactions (Monitor Closely)

  • Oral antihistamines: may increase sedation if systemic absorption occurs.
  • Other topical antifungals: concurrent use may increase local irritation.
  • Photosensitizing agents: advise sun protection as skin may be more sensitive.

Frequently Asked Questions

Mikanisal is a topical formulation containing ketoconazole that is used to treat superficial fungal skin infections such as tinea corporis (ringworm), tinea cruris (jock itch), tinea pedis (athlete’s foot), seborrheic dermatitis, and other dermatophyte or yeast infections of the skin.

Ketoconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesising ergosterol, a key component of the fungal cell membrane. Inhibiting this pathway disrupts membrane integrity, leading to fungal cell death and clearance of the infection.

The specific dosing regimen for Mikanisal is determined by the prescribing healthcare professional based on the infection type, severity, and patient characteristics. The prescriber will provide instructions on the amount to apply, frequency, and duration of treatment.

Safety data for topical ketoconazole during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Mikanisal.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Mikanisal (ketoconazole) belongs to the imidazole class and offers broad‑spectrum activity against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, ketoconazole may have a slightly slower onset but is effective for a wide range of superficial infections and is available in a convenient topical form.

Mikanisal should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keeping the product in a cool, dry place helps maintain its stability and potency throughout its shelf life.

The cream or lotion is applied to clean, dry skin in a thin layer over the affected area, usually once or twice daily as directed by the prescriber. Hands should be washed after application, and the treated area should be covered only if advised.

While rare, serious adverse reactions can include severe allergic contact dermatitis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and systemic effects such as liver toxicity if large skin areas are treated. Immediate medical attention is required if any signs of a severe reaction appear.

Mikanisal should be avoided in individuals with a known hypersensitivity to ketoconazole or any component of the formulation. Patients with extensive liver disease, those using interacting systemic medications, or individuals who are pregnant or breastfeeding without medical advice should also refrain from use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.